BeiGene
- Market cap
- 41.39B
- P/E (TTM)i
- 64.43
- P/Bi
- 8.00
- EPSi
- 2.53
- Div yieldi
- 0.00%
- 52W posi
- 84%
Anonymous reader poll. Unscientific, not investment advice.
Shares of BeiGene closed at 364.02, up 0.34%. Its market capitalisation is about 41.39B, the #538 most valuable US-listed company we track. The trailing P/E of 64.77 is 153% above its five-year average of 25.61. The 14 analysts covering the stock are, on balance, at Buy, targeting an average of 420.24 (+15%). Against a 52-week band of 253.95-385.22, the shares are currently 84% of the way up.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 weeks.
- Recent price momentum is +12.2% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 1.5% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation D-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 64.0x | Better than 9% |
| Forward P/E | 44.2x | Better than 10% |
| Price / Sales | 6.8x | Better than 19% |
| P/E vs own 5-yr range | 85th pctl | Better than 21% |
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability C+
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 87.5% | Better than 97% |
| Operating margin | 8.4% | Better than 29% |
| Net margin | 5.4% | Better than 29% |
| Return on equity | 7.5% | Better than 28% |
| Return on invested capital | 5.6% | Better than 31% |
Momentum A-
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 17.1% | Better than 84% |
| 6-month return | 19.0% | Better than 70% |
| 12-month return (ex latest month) | 4.0% | Better than 37% |
| Distance below 52-week high | 6.1% | Better than 88% |
Financial Health A
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 3.4x | Better than 86% |
| Debt to assets | 13.3% | Better than 73% |
| Interest coverage | 8.2x | Better than 59% |
| Free cash flow / net income | 300.1% | Better than 91% |
Analyst View B
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 80% |
| Upside to average target | 16.2% | Better than 30% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 362.78
- Open
- 360.01
- Day range
- 359.41 - 367.57
- Avg price
- 363.69
- Volume
- 148.64K
- Turnover
- 54.06M
- Turnover ratei
- 0.18%
- Volume ratioi
- 0.36
- Amplitudei
- 2.25%
- 52-week rangei
- 253.95 - 385.22
Valuation
- P/Ei
- 143.88
- P/E (TTM)i
- 64.43
- P/Bi
- 8.00
- EPSi
- 2.53
- Book value / shi
- 45.51
- Net profit
- 287.67M
- Net assets
- 5.17B
Share structure
- Market cap
- 41.39B
- Float capi
- 29.47B
- Shares out
- 113.70M
- Float sharesi
- 80.95M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2016-02-03
5.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+44.64M net over the window
Short interest
- Shares short
- 1.71M
- % of floati
- 1.50%
- Days to coveri
- 4.51
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of BeiGene (ONC)?
BeiGene last traded at 364.02. The quote on this page refreshes every few seconds while US markets are open.
What is BeiGene's market cap?
About 41.39B.
What is the P/E ratio of BeiGene?
The trailing twelve-month P/E is 64.43, above its own 5-year average of 25.61 — toward the top of its historical range (85.15% percentile). See the Valuation tab for the full history.
Does BeiGene pay a dividend?
BeiGene does not currently pay a regular dividend.
Is BeiGene a buy according to analysts?
The consensus of 14 analysts is a Buy rating, with an average 12-month price target of 420.24, which implies 15.4% upside from the current price. This is not investment advice.
What is BeiGene's StockVane Quant Rating?
The StockVane Momentum strategy currently rates BeiGene a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 05:10:03 · For reference only, not investment advice and not tailored to your situation.